Published March 22, 2002 | Version v1
Journal article

δ-Aminolevulinic acid cytotoxic effects on human hepatocarcinoma cell lines

  • 1. Centro de Investigaciones sobre Porfirinas y Porfirias (CIPYP), Argentine National Research Council (CONICET), Department of Biological Chemistry, FCEN, University of Buenos Aires (Argentina)

Description

Acute Intermittent Porphyria is a genetic disorder of heme metabolism, characterized by increased levels of porphyrin precursors, δ-aminolevulinic acid (ALA) and porphobilinogen (PBG). ALA has been reported to generate reactive oxygen species and to cause oxidative damage to proteins, subcellular structures and DNA. It is known that oxidative stress can induce apoptosis. The aim of this work was to study the cytotoxic effect of ALA on two hepatocarcinoma cell lines. We have determined the impact of ALA on HEP G2 and HEP 3B hepatocarcinoma cell lines survival as measured by the MTT assay. ALA proved to be cytotoxic in both cell lines however; HEP G2 was more sensitive to ALA than HEP 3B. Addition of hemin or glucose diminished ALA cytotoxicity in HEP G2 cells; instead it was enhanced in HEP 3B cells. Because apoptosis is usually associated with DNA fragmentation, the DNA of ALA treated and untreated cells were analyzed. The characteristic pattern of DNA fragmentation ladders was observed in ALA treated cells. To elucidate the mechanisms of ALA induced apoptosis, we examined its effect on p53 expression. No changes in p53 mRNA levels were observed after exposure of both cell lines to ALA for 24 h. CDK2 and CDK4 protein levels were reduced after ALA treatment at physiological concentrations

Availability note (English)

Available from http://dx.doi.org/10.1186/1471-2407-2-6; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC101407

Additional details

Publishing Information

Journal Title
BMC cancer (Online)
Journal Volume
2
Journal Page Range
p. 6
ISSN
1471-2407

Optional Information

Copyright
Copyright (c) 2002 De Siervi et al
Notes
PMCID: PMC101407; PUBLISHER-ID: 1471-2407-2-6; PMID: 11914144; OAI: oai:pubmedcentral.nih.gov:101407; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.